MapLight Therapeutics, Inc. (MPLT) Operating income 2024–2025
MapLight Therapeutics, Inc. (MPLT) annual operating income history from SEC filings — each fiscal year as reported.
-$169.1MFY2025 · since FY2024: -$82.9M → -$169.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$169.1M | -103.8% |
| FY2024 | -$82.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MPLT financial trends
MPLT RevenueMPLT Net incomeMPLT Net marginMPLT Gross profitMPLT Gross marginMPLT Operating marginMPLT Operating cash flowMPLT Free cash flowMPLT Capital expendituresMPLT Return on equityMPLT Stock buybacksMPLT Dividends paidMPLT Total assetsMPLT Total liabilitiesMPLT Shareholders’ equityMPLT overview →